Related Articles
Circulating tumor DNA analysis of metastatic renal cell carcinoma
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
Assessment of basal-like breast cancer by circulating tumor DNA analysis
Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study
Post‑radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma